At the news
? NEUTRALIMPACT 2/10 6-K filed Nov 12, 2026 at 16:00 ET
Ascendis Pharma filed its updated Articles of Association and disclosed a routine grant of 28,030 employee warrants at $256.59 per share. The filing is a governance update with no financial results or material business events.
- Board granted 28,030 warrants to employees on November 10, 2026 at $256.59 per share
- Warrants vest 25% after one year, then 1/36th monthly for remaining 75%
- After grant, 1,431,143 warrants remain available for future grant
- Articles of Association updated to reflect the grant and other historical warrant activity
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access